Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-immunogenic Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
Sponsor: National Society for Neurosonology and Cerebral Circulation
Summary
The study will collect data from aged 18 to 85 years with a diagnosis of acute stroke, who received thrombolytic treatment with a new agent, nonimmunogenic staphylokinase. Outcomes will be checked for safety and compared to the results of treatment with the other thrombolytic drug, alteplase.
Official title: Non-interventional Observational Study to Evaluate the Efficacy and Safety of Non-immune Staphylokinase in Reperfusion Therapy of Ischemic Stroke in Routine Clinical Practice
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
336
Start Date
2023-02-01
Completion Date
2030-05-10
Last Updated
2026-04-13
Healthy Volunteers
No
Conditions
Locations (1)
St. Petersburg Research Institute of Emergency Medicine named after I.I. Janelidze
Saint Petersburg, Russia